BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30676620)

  • 21. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
    Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
    Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
    Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
    Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.
    Giambartolomei C; Mueller CM; Greene MH; Korde LA
    Cancer Epidemiol; 2009 Jul; 33(1):31-6. PubMed ID: 19679044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of testicular cancer: a review.
    Martin FC; Conduit C; Loveland KL; Thomas B; Lewin J; Tran B
    Curr Opin Urol; 2022 Sep; 32(5):481-487. PubMed ID: 35855571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.
    Kanetsky PA; Mitra N; Vardhanabhuti S; Vaughn DJ; Li M; Ciosek SL; Letrero R; D'Andrea K; Vaddi M; Doody DR; Weaver J; Chen C; Starr JR; Håkonarson H; Rader DJ; Godwin AK; Reilly MP; Schwartz SM; Nathanson KL
    Hum Mol Genet; 2011 Aug; 20(15):3109-17. PubMed ID: 21551455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
    Brabrand S; Johannessen B; Axcrona U; Kraggerud SM; Berg KG; Bakken AC; Bruun J; Fosså SD; Lothe RA; Lehne G; Skotheim RI
    Neoplasia; 2015 Feb; 17(2):167-74. PubMed ID: 25748235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2.
    Hinić S; Cybulski C; Van der Post RS; Vos JR; Schuurs-Hoeijmakers J; Brugnoletti F; Koene S; Vreede L; van Zelst-Stams WAG; Kets CM; Haadsma M; Spruijt L; Wevers MR; Evans DG; Wimmer K; Schnaiter S; Volk AE; Möllring A; de Putter R; Soikkonen L; Kahre T; Tooming M; de Jong MM; Vaz F; Mensenkamp AR; Genuardi M; Lubinski J; Ligtenberg M; Hoogerbrugge N; de Voer RM
    Genet Med; 2024 May; 26(5):101101. PubMed ID: 38362852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
    Stolarova L; Kleiblova P; Zemankova P; Stastna B; Janatova M; Soukupova J; Achatz MI; Ambrosone C; Apostolou P; Arun BK; Auer P; Barnard M; Bertelsen B; ; Blok MJ; Boddicker N; Brunet J; Burnside ES; Calvello M; Campbell I; Chan SH; Chen F; Chiang JB; Coppa A; Cortesi L; Crujeiras-González A; ; De Leeneer K; De Putter R; DePersia A; Devereux L; Domchek S; Efremidis A; Engel C; Ernst C; Evans DGR; Feliubadaló L; Fostira F; Fuentes-Ríos O; Gómez-García EB; González S; Haiman C; Hansen TVO; Hauke J; Hodge J; Hu C; Huang H; Ishak NDB; Iwasaki Y; Konstantopoulou I; Kraft P; Lacey J; Lázaro C; Li N; Lim WK; Lindstrom S; Lori A; Martinez E; Martins A; Matsuda K; Matullo G; McInerny S; Michailidou K; Montagna M; Monteiro ANA; Mori L; Nathanson K; Neuhausen SL; Nevanlinna H; Olson JE; Palmer J; Pasini B; Patel A; Piane M; Poppe B; Radice P; Renieri A; Resta N; Richardson ME; Rosseel T; Ruddy KJ; Santamariña M; Dos Santos ES; Teras L; Toland AE; Trentham-Dietz A; Vachon CM; Volk AE; Weber-Lassalle N; Weitzel JN; Wiesmuller L; Winham S; Yadav S; Yannoukakos D; Yao S; Zampiga V; Zethoven M; Zhang ZW; Zima T; Spurdle AB; Vega A; Rossing M; Del Valle J; De Nicolo A; Hahnen E; Claes KBM; Ngeow J; Momozawa Y; James PA; Couch FJ; Macurek L; Kleibl Z
    Clin Cancer Res; 2023 Aug; 29(16):3037-3050. PubMed ID: 37449874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.
    Wagener R; Walter C; Auer F; Alzoubi D; Hauer J; Fischer U; Varghese J; Dugas M; Borkhardt A; Brozou T
    Int J Cancer; 2023 Apr; 152(7):1388-1398. PubMed ID: 36468172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans-generational epistasis between Dnd1Ter and other modifier genes controls susceptibility to testicular germ cell tumors.
    Lam MY; Heaney JD; Youngren KK; Kawasoe JH; Nadeau JH
    Hum Mol Genet; 2007 Sep; 16(18):2233-40. PubMed ID: 17616517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability.
    Nelson VR; Heaney JD; Tesar PJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2766-73. PubMed ID: 22923694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare inactivating PDE11A variants associated with testicular germ cell tumors.
    Pathak A; Stewart DR; Faucz FR; Xekouki P; Bass S; Vogt A; Zhang X; Boland J; Yeager M; Loud JT; Nathanson KL; McGlynn KA; Stratakis CA; Greene MH; Mirabello L
    Endocr Relat Cancer; 2015 Dec; 22(6):909-17. PubMed ID: 26459559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular microlithiasis as a familial risk factor for testicular germ cell tumour.
    Coffey J; Huddart RA; Elliott F; Sohaib SA; Parker E; Dudakia D; Pugh JL; Easton DF; Bishop DT; Stratton MR; Rapley EA
    Br J Cancer; 2007 Dec; 97(12):1701-6. PubMed ID: 17971766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of genetic susceptibility loci for testicular germ cell cancer in the Croatian population.
    Lessel D; Gamulin M; Kulis T; Toliat MR; Grgic M; Friedrich K; Zunec R; Balija M; Nürnberg P; Kastelan Z; Högel J; Kubisch C
    Carcinogenesis; 2012 Aug; 33(8):1548-52. PubMed ID: 22745383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDE11A gene polymorphism in testicular cancer: sperm parameters and hormonal profile.
    Faja F; Finocchi F; Carlini T; Rizzo F; Pallotti F; Spaziani M; Balercia G; Lenzi A; Paoli D; Lombardo F
    J Endocrinol Invest; 2021 Oct; 44(10):2273-2284. PubMed ID: 33661511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors.
    Koster R; Mitra N; D'Andrea K; Vardhanabhuti S; Chung CC; Wang Z; Loren Erickson R; Vaughn DJ; Litchfield K; Rahman N; Greene MH; McGlynn KA; Turnbull C; Chanock SJ; Nathanson KL; Kanetsky PA
    Hum Mol Genet; 2014 Nov; 23(22):6061-8. PubMed ID: 24943593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of proto-oncogene Dbl on Xq27 in testicular germ cell tumors reveals a rare SNP in a patient with bilateral undescended testis.
    Xu WH; Zhang C; Zhao WM; Li CM; Xiu YC; Ni SB; Ren MH; Sun DJ
    World J Urol; 2009 Dec; 27(6):811-5. PubMed ID: 19373475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
    Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
    JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for germline DND1 mutations in testicular cancer patients.
    Sijmons RH; Vos YJ; Herkert JC; Bos KK; Lutke Holzik MF; Hoekstra-Weebers JE; Hofstra RM; Hoekstra HJ
    Fam Cancer; 2010 Sep; 9(3):439-42. PubMed ID: 20411342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.